Penang Medical College Report issue

Academic/Hospital Phase 3 Phase 4
Founded: George Town Malaysia (1854)

Organization Overview

First Clinical Trial
2004
NCT01990118
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Clinical Research Centre, Penang Hospital | Clinical Research Centre, Penang Hospital, Malaysia | Department of Cardiology, Penang General Hospital, Penang 10990, Malaysia | Penang Hospital | Penang Hospital, Malaysia | Penang Hospital, Ministry of Health Malaysia | Penang Medical College, 4 Jalan Sepoy Lines, 11450, Penang, Malaysia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Attention Deficit Disorder with Hyperactivity (Phase 3)

Bronchiectasis (Phase 4)

Hyperkinesis (Phase 3)

Hyperparathyroidism (Phase 4)

Hyperparathyroidism, Secondary (Phase 4)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Neoplasm Metastasis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 12